Common Stock Warrants

The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio – Benzinga

The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio Benzinga … Continue reading

The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio – Benzinga Read More »

Warrantless but not unwarranted: Therapeutics Acquisition prices first ever SPAC IPO of common shares

Note from Dudley Pierce Baker, CommonStockWarrants.com I just saw this article out today and wanted to share it will my followers. If you follow the SPAC’s, blank check companies, this is the first offering without a stock warrant. Only shares were issued, not units, and thus no warrants which we frankly love to see as they are included in our database. I kind of doubt this will become a trend but I will be watching. Warrantless but not unwarranted: Therapeutics Acquisition prices first ever SPAC IPO of common shares July 8, 2020 2020’s blank check boom hit another major milestone with Therapeutics Acquisition (TXAC). For the first time in their roughly 20-year history, a SPAC has completed an IPO by selling common shares rather than units, signaling ever-greater demand in the space. SPAC offerings normally include units consisting of shares of common stock and tradable warrants. Therapeutics Acquisition marks a notable first, but it is also part of a trend, with more SPACs this year lowering their warrant component to 1/3 and 1/4 warrants. 2020 SPAC milestones The first ever SPAC IPO of common shares: Therapeutics Acquisition (TXAC) The largest SPAC ever to go public: Churchill Capital Corp III (CCXXU) The largest SPAC ever to file for an IPO: Pershing Square Tontine (PSTH.U) The biggest quarter ever by proceeds (tied for most deals): 2Q20, 24 SPACs and $7.2 billion On pace for a record year in 2020 Several companies have chosen SPAC listings over IPOs   Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million … Continue reading

Warrantless but not unwarranted: Therapeutics Acquisition prices first ever SPAC IPO of common shares Read More »

Big Funds To Pull Money Out Of Stocks: 2ND Wave To Hit Economy

July 06, 2020 Chris Vermeulen TheTechnicalTraders.com Note from Dudley – These Guys Are Good: Chris and his team are providing investors with a great road map for the direction of the markets, which is why I am also a paid subscriber to TheTechnicalTraders services and encourage you to consider a subscription as well, The ideal service to supplement your other subscriptions as well as my CommonStockWarrants.com. Stock Warrants – If Not Now, When? GET STARTED NOW   BIG FUNDS TO PULL MONEY OUT OF STOCKS: 2ND WAVE TO HIT ECONOMY   SILVER EXITS BEAR MARKET ONCE IT GOES ABOVE $21 WILD VOLATILITY CONTINUES AS US MARKETS ATTEMPT TO ESTABLISH NEW TREND GOLD COMPLETES ANOTHER WASHOUT ROTATION – HERE WE GO   ALL THAT GLITTERS WHEN THE WORLD JITTERS IS PROBABLY GOLD   Investors don’t forget the great opportunities available with stock warrants which will increase your potential gains and greatly decrease your investment cost by at least half. E.B. Tucker with Casey Research recently referred to Dudley as ‘the top expert in the field with over 40 years of experience‘ with stock warrants. “I also encourage you to check out the work from our friend Dudley Baker. Dudley is the founder and editor of Common Stock Warrants. He’s been trading warrants for 40 years and has developed an exclusive database of all stock warrants trading in the U.S. and Canada. We’re paid-up subscribers as well.” Jeff Baker Senior Analyst – Admin/Web Developer B.Sc. Geological Sciences (UTEP) Common Stock Warrants & Junior Mining … Continue reading

Big Funds To Pull Money Out Of Stocks: 2ND Wave To Hit Economy Read More »